Identification of Small Molecules Inhibiting Cardiomyocyte Necrosis and Apoptosis by Autophagy Induction and Metabolism Reprogramming.
Dawei LiuFélix PeyreYahir Alberto Loissell-BaltazarDelphine CourilleauSandra Lacas-GervaisValérie NicolasEric JacquetSvetlana DokudovskayaFrédéric TaranJean-Christophe CintratCatherine BrennerPublished in: Cells (2022)
Improvement of anticancer treatments is associated with increased survival of cancer patients at risk of cardiac disease. Therefore, there is an urgent need for new therapeutic molecules capable of preventing acute and long-term cardiotoxicity. Here, using commercial and home-made chemolibraries, we performed a robust phenotypic high-throughput screening in rat cardiomyoblast cell line H9c2, searching for small molecules capable of inhibiting cell death. A screen of 1600 compounds identified six molecules effective in preventing necrosis and apoptosis induced by H 2 O 2 and camptothecin in H9c2 cells and in rat neonatal ventricular myocytes. In cells treated with these molecules, we systematically evaluated the expression of BCL-2 family members, autophagy progression, mitochondrial network structure, regulation of mitochondrial fusion/fission, reactive oxygen species, and ATP production. We found that these compounds affect autophagy induction to prevent cardiac cell death and can be promising cardioprotective drugs during chemotherapy.
Keyphrases
- cell death
- cell cycle arrest
- oxidative stress
- induced apoptosis
- endoplasmic reticulum stress
- signaling pathway
- left ventricular
- pi k akt
- reactive oxygen species
- heart failure
- poor prognosis
- healthcare
- squamous cell carcinoma
- cell proliferation
- high throughput
- liver failure
- locally advanced
- respiratory failure
- angiotensin ii
- drug induced
- radiation therapy
- rectal cancer
- extracorporeal membrane oxygenation
- catheter ablation
- single cell